FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer

SIMPLE SUMMARY: In the last decade, immunotherapy has revolutionized the treatment of malignant melanoma and non-small cell lung cancer. Even though both tumor types have the highest tumor mutational burden, a non-negligible portion of patients do not benefit from checkpoint inhibitor treatment. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Grell, Peter, Borilova, Simona, Fabian, Pavel, Selingerova, Iveta, Novak, David, Muller, Petr, Kiss, Igor, Vyzula, Rostislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047850/
https://www.ncbi.nlm.nih.gov/pubmed/36980787
http://dx.doi.org/10.3390/cancers15061901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047850/
https://www.ncbi.nlm.nih.gov/pubmed/36980787
http://dx.doi.org/10.3390/cancers15061901

Ejemplares similares